The global allergy immunotherapy market is expected to exhibit a strong 10.85% CAGR over the forecast period from 2017 to 2023, with the market rising to a valuation of USD 4,324.7 million, according to the latest research report from Market Research Future (MRFR).
Free Sample Copy With Considering Coivd19 Impact on this Market @ https://www.marketresearchfuture.com/sample_request/1517
Growing Allergens Exposure Is Driving A Strong Market Growth
According to the World Allergy Organization (WAO), estimates approximately 10 % to 40 % of the global population is suffering from an allergy in 2015. Growing prevalence of various chronic diseases like allergy, asthma, diabetes, and hypertension is driving the market growth. Increasing exposure to allergens owing to large-scale pollution is another driver of the market. The rapid adoption of Allergy Immunotherapy due to technological advancements and robust research pipeline is driving further market growth.
Market Segmentation
The
Market Research Future report provides an all-inclusive segmental
analysis of the allergy immunotherapy market on the basis of treatment
and allergy type.
Based on allergy type, the allergy immunotherapy market is segmented into peanut allergy, allergic rhinitis, allergic asthma, cat allergy, and other allergies. Of these, the allergic rhinitis segment will have the largest share in the market during the forecast period chiefly owing to its growing prevalence among children and adults alike.
Based on treatment, the allergy immunotherapy market is segmented into specific immunotherapy (SIT), subcutaneous immunotherapy (SCIT), and sublingual immunotherapy. The sublingual immunotherapy segment is again segmented into sublingual immunotherapy drops and sublingual immunotherapy tablets. Of these, the subcutaneous immunotherapy segment will dominate the market during the forecast period. Factors pushing the growth of this segment include its effectiveness in treating various types of allergies, such as asthma. Moreover, this is a treatment option that alters the immune system for preventing the development of other types of allergies.
Competitive Analysis:
Leading players in the global Allergy Immunotherapy by Type include HAL Allergy Group, Merck KGaA (Allergopharma), Stallergenes Greer, DBV Technologies, Circassia, Allergy Therapeutics, and ALK Abello A/S.
In August 2019, a new trial was launched by the NIH, Genentech, and Novartis to assess the impact of experimental treatments for various food allergies.
Regional Analysis
By region, the allergy immunotherapy market report covers the latest trends and growth opportunities across the Americas, the Middle East and Africa, the Asia Pacific, and Europe. Of these, Europe will dominate the market over the forecast period. Factors pushing the growth of the allergy immunotherapy market in the region include increasing incidence of various chronic diseases such as hypertension, diabetes, allergy, and asthma, growing awareness about allergy immunotherapy treatments, and elevated occurrence of skin allergy and allergic rhinitis.
The allergy immunotherapy market in North America is predicted to have a healthy growth over the forecast period owing to increasing awareness about allergy as well as its treatment along with the availability of effective products.
The allergy immunotherapy market in the APAC region is predicted to have a significant growth during the forecast period for rising awareness of treatments coupled with mounting healthcare spending.
The global allergy immunotherapy market in the Middle East and Africa is predicted to have a small growth over the forecast period.
Key Players
Major players profiled in the allergy immunotherapy market report include HAL Allergy Group (Netherlands), Stallergenes Greer (UK), ALK Abello A/S (Denmark), DBV Technologies (France), Circassia (UK), Merck KGaA (Allergopharma) (Germany), and Allergy Therapeutics (UK), among others.
Industry News
October 2019: A graduate student from the department of immunology in the Max Rady College of Medicine has developed a new drug for combating allergic asthma.
1 Report Prologue
2 Market Introduction
2.1 Introduction 18
2.2 Scope of Study 18
2.3 Research Objective 19
2.4 Assumptions & Limitations 19
2.4.1 Assumptions 19
2.4.2 Limitations 19
2.5 Market Structure 20
3 Research Methodology
3.1 Research Process 21
3.2 Primary Research 22
3.3 Secondary Research 22
3.4 Market Size Estimation 22
3.5 Forecast Model 24
4 Market Dynamics
4.1 Introduction 25
4.2 Drivers 25
4.2.1 Launch of New sublingual Immunotherapies in emerging Economies will Drive the Growth of the Market 25
4.2.2 Major Players are introducing Several Allergen Immunotherapy Tablets (AITs) in Potential Markets 26
4.2.3 Increase in risk Factors Causing Allergies 26
4.2.4 Rising Screening for Allergy and reimbursement Scenario 26
4.3 Restraint 27
4.3.1 Restricted Healthcare Spending in underserved Market of Europe will Restrain the Growth 27
4.4 Opportunity 27
4.4.1 Allergy Immune Therapies will be Launched in the US. 27
4.5 Challenges 28
4.5.1 High Cost of Allergy Immunotherapy 28
4.6 Micro Economic Indicators 28
5 Market Factor Analysis
5.1 Porter’s Five Forces Model 30
5.1.1 Bargaining Power of Suppliers 31
5.1.2 Bargaining Power of Buyers 31
5.1.3 Threat of New Entrants 31
5.1.4 Threat of Substitutes 31
5.1.5 Intensity of Rivalry 31
5.2 Supply Chain Analysis 32
5.2.1 R&D 32
5.2.2 Parts Manufacturing 33
5.2.3 Distribution 33
5.2.4 Marketing & Sales 33
5.2.5 Post-Sales Monitoring 33
5.3 Pricing Analysis 33
5.4 Investment Opportunity Analysis 34
5.5 Merger and Acquisition Landscape 35
Click here to get the short-term and long-term impact of COVID-19 on this Market: https://www.marketresearchfuture.com/reports/allergy-immunotherapy-market-1517
Related Reports Links:-
Quality Control in Pharma Industry
Nystagmus Blockage Syndrome
Veterinary Management Software Research Paper
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half- Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
0 Comments